ECM
GDRX icon

Engle Capital Management’s GoodRx Holdings GDRX Stock Holding History

Engle Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-112,000
Closed -$4.52M – 24
2020
Q4 		$4.52M Buy
+112,000
New +$5.15M 0.65% 22

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Engle Capital Management's GDRX Position: Q1 2021 in Review

Engle Capital Management sold out of GoodRx Holdings (GDRX) in Q1 2021, closing a stake of 112,000 shares — an estimated $4.52M sold.

Engle Capital Management first reported a position in GDRX in Q4 2020 and held it in 1 quarter. The position peaked at $4.52M in Q4 2020. 205 funds tracked by Wall St. Rank hold GDRX as of Q1 2021.

  • Engle Capital Management reported no remaining GoodRx Holdings position as of Q1 2021 after selling out during the quarter.
  • Engle Capital Management sold 112,000 GoodRx Holdings shares in Q1 2021, an estimated $4.52M.
  • Engle Capital Management first reported a position in GoodRx Holdings in Q4 2020 and held it in 1 quarter.
  • Engle Capital Management's GoodRx Holdings position peaked at $4.52M in Q4 2020.
  • 205 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2021.

Based on Engle Capital Management's 13F filing for Q1 2021, filed 17 May 2021.